These press releases are intended for business journalists and analysts/investors
- GSK Australia supplies travel vaccines for Olympic Team
- Changes trigger better access to the treatment of enlarged prostate
- GPs set to play a more prominent role in managing moderate to severe BPH.
Resumed supply of Zovirax Ophthalmic Ointment confirmed following a global supply shortage.
We are recalling two batches of Children’s Panadol 5-12 Suspension Strawberry (200mL) and one batch of Children’s Panadol 5-12 Suspension Orange (200mL)
GlaxoSmithKline (GSK) Australia has reported its 2015 results to the Australian Securities and Investment Commission (ASIC) for its pharmaceuticals and vaccines business, as well as GSK Consumer Healthcare (a joint venture with Novartis) and ViiV (a joint venture with Pfizer and Shionogi focused on HIV).
In 2015, GSK Australia made payments totalling $3.6 million to healthcare professionals (HCPs) and health-related organisations (HCOs) for grants, sponsorships and consultancy fees related to chairing and speaking at meetings, assistance with training and participation in advisory boards.
GSK has responded to the state of emergency declared in Fiji by providing funding and urgent supplies of medicine.
We are one of the world’s largest science-led pharmaceutical and healthcare companies. Each year we research, manufacture and sell innovative medicines, vaccines and healthcare products for millions of people across the world, helping them to do more, feel better and live longer.